CD8A and endometrial cancer: CD8+ T cells are known to inhibit tumor angiogenesis by secreting IFN-γ [19, 34], whereas the presence of CD25+/FOXP3+ tumor-infiltrating lymphocytes reportedly correlates with promoting intratumoral angiogenesis in multiple sorts of cancer including endometrial cancer [14–16].